Product NDC: | 11994-011 |
Proprietary Name: | Definity |
Non Proprietary Name: | perflutren |
Active Ingredient(s): | 6.52 mg/mL & nbsp; perflutren |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11994-011 |
Labeler Name: | Lantheus Medical Imaging, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021064 |
Marketing Category: | NDA |
Start Marketing Date: | 20010721 |
Package NDC: | 11994-011-04 |
Package Description: | 4 VIAL, GLASS in 1 CARTON (11994-011-04) > 1.5 mL in 1 VIAL, GLASS |
NDC Code | 11994-011-04 |
Proprietary Name | Definity |
Package Description | 4 VIAL, GLASS in 1 CARTON (11994-011-04) > 1.5 mL in 1 VIAL, GLASS |
Product NDC | 11994-011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | perflutren |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20010721 |
Marketing Category Name | NDA |
Labeler Name | Lantheus Medical Imaging, Inc. |
Substance Name | PERFLUTREN |
Strength Number | 6.52 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Contrast Agent for Ultrasound Imaging [EPC],Ultrasound Contrast Activity [MoA] |